RESPONSE TO: COST-SHARING: IMPLICATIONS OF A WELL-INTENDED BENEFITS STRATEGY.

Rotolo, Shannon M · J Manag Care Spec Pharm · 2022

Where this comes from

Abstract

<b>Disclosures:</b> S. Rotolo has no conflicts of interest to disclose. No funding was received for any portion of this work.

Medical subject headings